Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-07-28

AUTHORS

Kirsty M. Cuthill, Yan Zhang, Andrea Pepper, Lies Boelen, Eve Coulter, Becca Asquith, Stephen Devereux, Derek C. Macallan

ABSTRACT

Pathogenesis in chronic lymphocytic leukemia (CLL) is strongly linked to the potential for leukemic cells to migrate to and proliferate within lymph-nodes. Previous in vivo studies suggest that all leukemic cells participate in cycles of migration and proliferation. In vitro studies, however, have shown heterogeneous migration patterns.To investigate tumor subpopulation kinetics, we performed in vivo isotope-labeling studies in ten patients with IgVH-mutated CLL (M-CLL). Using deuterium-labeled glucose, we investigated proliferation in sub-populations defined by CXCR4/CD5 and surface (sIgM) expression. Mathematical modeling was performed to test the likelihood that leukemic cells exist as distinct sub-populations or as a single population with the same proliferative capacity. Further labeling studies in two patients with M-CLL commencing idelalisib investigated the effect of B-cell receptor (BCR) antagonists on sub-population kinetics.Modeling revealed that data were more consistent with a model comprising distinct sub-populations (p = 0.008) with contrasting, characteristic kinetics. Following idelalisib therapy, similar labeling suppression across all sub-populations suggested that the most proliferative subset is the most sensitive to treatment. As the quiescent sub-population precedes treatment, selection likely explains the persistence of such residual non-proliferating populations during BCR-antagonist therapy. These findings have clinical implications for discontinuation of long-term BCR-antagonist treatment in selected patients. More... »

PAGES

2233-2241

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41375-022-01656-4

DOI

http://dx.doi.org/10.1038/s41375-022-01656-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149816730

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35902732


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Haematology, King\u2019s College Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.46699.34", 
          "name": [
            "Department of Haematology, King\u2019s College Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cuthill", 
        "givenName": "Kirsty M.", 
        "id": "sg:person.01017273411.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017273411.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Infection and Immunity, St George\u2019s, University of London, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.4464.2", 
          "name": [
            "Institute for Infection and Immunity, St George\u2019s, University of London, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Yan", 
        "id": "sg:person.0616407464.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616407464.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brighton and Sussex Medical School, Medical Research Building, University of Sussex, Brighton, UK", 
          "id": "http://www.grid.ac/institutes/grid.414601.6", 
          "name": [
            "Brighton and Sussex Medical School, Medical Research Building, University of Sussex, Brighton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pepper", 
        "givenName": "Andrea", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Infectious Disease, Imperial College, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.7445.2", 
          "name": [
            "Department of Infectious Disease, Imperial College, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boelen", 
        "givenName": "Lies", 
        "id": "sg:person.01164315757.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164315757.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Cancer Genomics and Computational Biology, Bart\u2019s Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.4868.2", 
          "name": [
            "Centre for Cancer Genomics and Computational Biology, Bart\u2019s Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coulter", 
        "givenName": "Eve", 
        "id": "sg:person.01235005155.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235005155.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Infectious Disease, Imperial College, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.7445.2", 
          "name": [
            "Department of Infectious Disease, Imperial College, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asquith", 
        "givenName": "Becca", 
        "id": "sg:person.01354404447.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354404447.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devereux", 
        "givenName": "Stephen", 
        "id": "sg:person.0711352621.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711352621.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Infection Care Group, St George\u2019s University Hospitals NHS Foundation Trust, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.451349.e", 
          "name": [
            "Institute for Infection and Immunity, St George\u2019s, University of London, London, UK", 
            "Infection Care Group, St George\u2019s University Hospitals NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Macallan", 
        "givenName": "Derek C.", 
        "id": "sg:person.01002636634.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002636634.96"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/gm451", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024305027", 
          "https://doi.org/10.1186/gm451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2017.11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014356264", 
          "https://doi.org/10.1038/leu.2017.11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nprot.2007.420", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009851228", 
          "https://doi.org/10.1038/nprot.2007.420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2119/molmed.2011.00360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068965464", 
          "https://doi.org/10.2119/molmed.2011.00360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/371389a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035657734", 
          "https://doi.org/10.1038/371389a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2014.122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004020249", 
          "https://doi.org/10.1038/leu.2014.122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nprot.2009.117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031891397", 
          "https://doi.org/10.1038/nprot.2009.117"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-28", 
    "datePublishedReg": "2022-07-28", 
    "description": "Pathogenesis in chronic lymphocytic leukemia (CLL) is strongly linked to the potential for leukemic cells to migrate to and proliferate within lymph-nodes. Previous in vivo studies suggest that all leukemic cells participate in cycles of migration and proliferation. In vitro studies, however, have shown heterogeneous migration patterns.To investigate tumor subpopulation kinetics, we performed in vivo isotope-labeling studies in ten patients with IgVH-mutated CLL (M-CLL). Using deuterium-labeled glucose, we investigated proliferation in sub-populations defined by CXCR4/CD5 and surface (sIgM) expression. Mathematical modeling was performed to test the likelihood that leukemic cells exist as distinct sub-populations or as a single population with the same proliferative capacity. Further labeling studies in two patients with M-CLL commencing idelalisib investigated the effect of B-cell receptor (BCR) antagonists on sub-population kinetics.Modeling revealed that data were more consistent with a model comprising distinct sub-populations (p\u2009=\u20090.008) with contrasting, characteristic kinetics. Following idelalisib therapy, similar labeling suppression across all sub-populations suggested that the most proliferative subset is the most sensitive to treatment. As the quiescent sub-population precedes treatment, selection likely explains the persistence of such residual non-proliferating populations during BCR-antagonist therapy. These findings have clinical implications for discontinuation of long-term BCR-antagonist treatment in selected patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41375-022-01656-4", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7551419", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "keywords": [
      "chronic lymphocytic leukemia", 
      "leukemic cells", 
      "idelalisib therapy", 
      "lymph nodes", 
      "receptor antagonist", 
      "lymphocytic leukemia", 
      "clinical implications", 
      "patients", 
      "vivo studies", 
      "same proliferative capacity", 
      "proliferative capacity", 
      "surface expression", 
      "non-proliferating population", 
      "proliferative subset", 
      "therapy", 
      "treatment", 
      "cells", 
      "proliferation", 
      "discontinuation", 
      "idelalisib", 
      "CD5", 
      "pathogenesis", 
      "population", 
      "leukemia", 
      "antagonist", 
      "characteristic kinetics", 
      "study", 
      "IgVH", 
      "subpopulations", 
      "labeling studies", 
      "glucose", 
      "expression", 
      "suppression", 
      "findings", 
      "single population", 
      "subset", 
      "likelihood", 
      "persistence", 
      "effect", 
      "migration", 
      "patterns", 
      "identification", 
      "data", 
      "migration patterns", 
      "potential", 
      "implications", 
      "capacity", 
      "cycle", 
      "kinetics", 
      "selection", 
      "deuterium-labeled glucose", 
      "model", 
      "heterogeneous migration patterns", 
      "mathematical modeling", 
      "cycles of migration", 
      "modeling", 
      "isotope labeling studies"
    ], 
    "name": "Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL", 
    "pagination": "2233-2241", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149816730"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41375-022-01656-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35902732"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41375-022-01656-4", 
      "https://app.dimensions.ai/details/publication/pub.1149816730"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_953.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41375-022-01656-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01656-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01656-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01656-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01656-4'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      21 PREDICATES      89 URIs      74 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41375-022-01656-4 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nfaa4c184d2f14014a18101e882ac1ee3
4 schema:citation sg:pub.10.1038/371389a0
5 sg:pub.10.1038/leu.2014.122
6 sg:pub.10.1038/leu.2017.11
7 sg:pub.10.1038/nprot.2007.420
8 sg:pub.10.1038/nprot.2009.117
9 sg:pub.10.1186/gm451
10 sg:pub.10.2119/molmed.2011.00360
11 schema:datePublished 2022-07-28
12 schema:datePublishedReg 2022-07-28
13 schema:description Pathogenesis in chronic lymphocytic leukemia (CLL) is strongly linked to the potential for leukemic cells to migrate to and proliferate within lymph-nodes. Previous in vivo studies suggest that all leukemic cells participate in cycles of migration and proliferation. In vitro studies, however, have shown heterogeneous migration patterns.To investigate tumor subpopulation kinetics, we performed in vivo isotope-labeling studies in ten patients with IgVH-mutated CLL (M-CLL). Using deuterium-labeled glucose, we investigated proliferation in sub-populations defined by CXCR4/CD5 and surface (sIgM) expression. Mathematical modeling was performed to test the likelihood that leukemic cells exist as distinct sub-populations or as a single population with the same proliferative capacity. Further labeling studies in two patients with M-CLL commencing idelalisib investigated the effect of B-cell receptor (BCR) antagonists on sub-population kinetics.Modeling revealed that data were more consistent with a model comprising distinct sub-populations (p = 0.008) with contrasting, characteristic kinetics. Following idelalisib therapy, similar labeling suppression across all sub-populations suggested that the most proliferative subset is the most sensitive to treatment. As the quiescent sub-population precedes treatment, selection likely explains the persistence of such residual non-proliferating populations during BCR-antagonist therapy. These findings have clinical implications for discontinuation of long-term BCR-antagonist treatment in selected patients.
14 schema:genre article
15 schema:isAccessibleForFree true
16 schema:isPartOf N2afe46189f04423fba69c37f6aabe991
17 N924b5e01554540f9a7abf199fc6c5755
18 sg:journal.1097065
19 schema:keywords CD5
20 IgVH
21 antagonist
22 capacity
23 cells
24 characteristic kinetics
25 chronic lymphocytic leukemia
26 clinical implications
27 cycle
28 cycles of migration
29 data
30 deuterium-labeled glucose
31 discontinuation
32 effect
33 expression
34 findings
35 glucose
36 heterogeneous migration patterns
37 idelalisib
38 idelalisib therapy
39 identification
40 implications
41 isotope labeling studies
42 kinetics
43 labeling studies
44 leukemia
45 leukemic cells
46 likelihood
47 lymph nodes
48 lymphocytic leukemia
49 mathematical modeling
50 migration
51 migration patterns
52 model
53 modeling
54 non-proliferating population
55 pathogenesis
56 patients
57 patterns
58 persistence
59 population
60 potential
61 proliferation
62 proliferative capacity
63 proliferative subset
64 receptor antagonist
65 same proliferative capacity
66 selection
67 single population
68 study
69 subpopulations
70 subset
71 suppression
72 surface expression
73 therapy
74 treatment
75 vivo studies
76 schema:name Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL
77 schema:pagination 2233-2241
78 schema:productId N0992c8b4367948f38344f56048d0629e
79 N310e63ed03784d4db55a13e8a7ef61c4
80 N7172453d842541618c5d44c09f80d42b
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149816730
82 https://doi.org/10.1038/s41375-022-01656-4
83 schema:sdDatePublished 2022-09-02T16:07
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N1e001b195ecd48508b3fc401b2c656ac
86 schema:url https://doi.org/10.1038/s41375-022-01656-4
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N0582be039d6f470d8586c874d6941456 rdf:first sg:person.01235005155.41
91 rdf:rest Nbe3c15cb9c374080909623dd7b5a75b8
92 N0992c8b4367948f38344f56048d0629e schema:name doi
93 schema:value 10.1038/s41375-022-01656-4
94 rdf:type schema:PropertyValue
95 N0de0119f586345999169fdcd25c295e8 rdf:first sg:person.01002636634.96
96 rdf:rest rdf:nil
97 N1e001b195ecd48508b3fc401b2c656ac schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 N2afe46189f04423fba69c37f6aabe991 schema:volumeNumber 36
100 rdf:type schema:PublicationVolume
101 N310e63ed03784d4db55a13e8a7ef61c4 schema:name pubmed_id
102 schema:value 35902732
103 rdf:type schema:PropertyValue
104 N7172453d842541618c5d44c09f80d42b schema:name dimensions_id
105 schema:value pub.1149816730
106 rdf:type schema:PropertyValue
107 N7e920831be674b8c96f523d9bae25f9a rdf:first Na55c0d53d53841f984c13e9a6d83396c
108 rdf:rest Nafa6ae8b10314676945f8b9decccf35d
109 N7fffd0c1259943d7a7bca091fefd1f40 rdf:first sg:person.0616407464.21
110 rdf:rest N7e920831be674b8c96f523d9bae25f9a
111 N924b5e01554540f9a7abf199fc6c5755 schema:issueNumber 9
112 rdf:type schema:PublicationIssue
113 Na55c0d53d53841f984c13e9a6d83396c schema:affiliation grid-institutes:grid.414601.6
114 schema:familyName Pepper
115 schema:givenName Andrea
116 rdf:type schema:Person
117 Nafa6ae8b10314676945f8b9decccf35d rdf:first sg:person.01164315757.19
118 rdf:rest N0582be039d6f470d8586c874d6941456
119 Nb2accd16336c4316ad411e74c82efa6f rdf:first sg:person.0711352621.84
120 rdf:rest N0de0119f586345999169fdcd25c295e8
121 Nbe3c15cb9c374080909623dd7b5a75b8 rdf:first sg:person.01354404447.26
122 rdf:rest Nb2accd16336c4316ad411e74c82efa6f
123 Nfaa4c184d2f14014a18101e882ac1ee3 rdf:first sg:person.01017273411.32
124 rdf:rest N7fffd0c1259943d7a7bca091fefd1f40
125 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
126 schema:name Medical and Health Sciences
127 rdf:type schema:DefinedTerm
128 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
129 schema:name Cardiorespiratory Medicine and Haematology
130 rdf:type schema:DefinedTerm
131 sg:grant.7551419 http://pending.schema.org/fundedItem sg:pub.10.1038/s41375-022-01656-4
132 rdf:type schema:MonetaryGrant
133 sg:journal.1097065 schema:issn 0887-6924
134 1476-5551
135 schema:name Leukemia
136 schema:publisher Springer Nature
137 rdf:type schema:Periodical
138 sg:person.01002636634.96 schema:affiliation grid-institutes:grid.451349.e
139 schema:familyName Macallan
140 schema:givenName Derek C.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002636634.96
142 rdf:type schema:Person
143 sg:person.01017273411.32 schema:affiliation grid-institutes:grid.46699.34
144 schema:familyName Cuthill
145 schema:givenName Kirsty M.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017273411.32
147 rdf:type schema:Person
148 sg:person.01164315757.19 schema:affiliation grid-institutes:grid.7445.2
149 schema:familyName Boelen
150 schema:givenName Lies
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164315757.19
152 rdf:type schema:Person
153 sg:person.01235005155.41 schema:affiliation grid-institutes:grid.4868.2
154 schema:familyName Coulter
155 schema:givenName Eve
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235005155.41
157 rdf:type schema:Person
158 sg:person.01354404447.26 schema:affiliation grid-institutes:grid.7445.2
159 schema:familyName Asquith
160 schema:givenName Becca
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354404447.26
162 rdf:type schema:Person
163 sg:person.0616407464.21 schema:affiliation grid-institutes:grid.4464.2
164 schema:familyName Zhang
165 schema:givenName Yan
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616407464.21
167 rdf:type schema:Person
168 sg:person.0711352621.84 schema:affiliation grid-institutes:grid.13097.3c
169 schema:familyName Devereux
170 schema:givenName Stephen
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711352621.84
172 rdf:type schema:Person
173 sg:pub.10.1038/371389a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035657734
174 https://doi.org/10.1038/371389a0
175 rdf:type schema:CreativeWork
176 sg:pub.10.1038/leu.2014.122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004020249
177 https://doi.org/10.1038/leu.2014.122
178 rdf:type schema:CreativeWork
179 sg:pub.10.1038/leu.2017.11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014356264
180 https://doi.org/10.1038/leu.2017.11
181 rdf:type schema:CreativeWork
182 sg:pub.10.1038/nprot.2007.420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009851228
183 https://doi.org/10.1038/nprot.2007.420
184 rdf:type schema:CreativeWork
185 sg:pub.10.1038/nprot.2009.117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031891397
186 https://doi.org/10.1038/nprot.2009.117
187 rdf:type schema:CreativeWork
188 sg:pub.10.1186/gm451 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024305027
189 https://doi.org/10.1186/gm451
190 rdf:type schema:CreativeWork
191 sg:pub.10.2119/molmed.2011.00360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068965464
192 https://doi.org/10.2119/molmed.2011.00360
193 rdf:type schema:CreativeWork
194 grid-institutes:grid.13097.3c schema:alternateName Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King’s College London, London, UK
195 schema:name Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences and Medicine, King’s College London, London, UK
196 rdf:type schema:Organization
197 grid-institutes:grid.414601.6 schema:alternateName Brighton and Sussex Medical School, Medical Research Building, University of Sussex, Brighton, UK
198 schema:name Brighton and Sussex Medical School, Medical Research Building, University of Sussex, Brighton, UK
199 rdf:type schema:Organization
200 grid-institutes:grid.4464.2 schema:alternateName Institute for Infection and Immunity, St George’s, University of London, London, UK
201 schema:name Institute for Infection and Immunity, St George’s, University of London, London, UK
202 rdf:type schema:Organization
203 grid-institutes:grid.451349.e schema:alternateName Infection Care Group, St George’s University Hospitals NHS Foundation Trust, London, UK
204 schema:name Infection Care Group, St George’s University Hospitals NHS Foundation Trust, London, UK
205 Institute for Infection and Immunity, St George’s, University of London, London, UK
206 rdf:type schema:Organization
207 grid-institutes:grid.46699.34 schema:alternateName Department of Haematology, King’s College Hospital, London, UK
208 schema:name Department of Haematology, King’s College Hospital, London, UK
209 rdf:type schema:Organization
210 grid-institutes:grid.4868.2 schema:alternateName Centre for Cancer Genomics and Computational Biology, Bart’s Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, UK
211 schema:name Centre for Cancer Genomics and Computational Biology, Bart’s Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, UK
212 rdf:type schema:Organization
213 grid-institutes:grid.7445.2 schema:alternateName Department of Infectious Disease, Imperial College, London, UK
214 schema:name Department of Infectious Disease, Imperial College, London, UK
215 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...